KLKarin van Leeuwen

Karin van Leeuwen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Karin van Leeuwen has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Bleeding Symptoms, Laboratory, and Molecular Genetic Results in Children With Platelet Disorders

    by Elise J. Huisman, Ferdows Atiq, Caroline S. B. Veen, Leo van de Watering, A. Marieke Joosten, Karin van Leeuwen, Leendert Porcelijn, Marieke J. H. A. Kruip, Masja de Haas, Marjon H. Cnossen

    Diagnosing and classifying platelet disorders (PD) is challenging in children. Therefore, we evaluated clinical, laboratory, and genetic data to improve current algorithms by performing a prospective observational cohort study in children (0–18 years) with a known genetic cause (proven PD), functional abnormalities, or thrombocytopenia without genetic cause (probable PD) or medical suspicion of PD (possible PD). We included 98 children (mean age 11.6 years, 55 females). PD was proven in 44, probable in 43, and possible in 11. Comorbidities were present in 43. Epistaxis, hematomas, menstrual, and perioperative bleeding were reported most frequently. Mean ISTH‐BAT bleeding score was 6.1 (SD 4.0, range 0–17), with higher scores in post‐pubertal females (mean 7.6) and lower scores in children with moderate thrombocytopenia (mean 4.8). Bleeding as a presenting symptom and older age were associated with higher bleeding scores. Treatment was indicated in 46 children. Most frequently, Light transmission aggregometry was abnormal for ADP, epinephrine, and thrombin. General laboratory parameters can hint to but not identify PD origin. Genetic testing led to novel diagnoses in 10 (23%) children with probable PD. We conclude that bleeding tendency is prominent but variable in children with PD. Routine laboratory tests are useful, but fail to diagnose the origin of PD. Therefore, genetic analysis is essential, especially as PD can be part of a syndrome leading to comorbidities or predispose for malignancies, both impacting counseling and surveillance. We propose a classification based on functional and genetic analysis leading to either an isolated or syndrome‐associated inherited PD or a functional PD. Trial Registration: ABR NL55101.078.16

  • Open Access

    Clinical and laboratory findings in patients with leukocyte adhesion deficiency type I: A multicenter study in Turkey

    by Ismail Yaz, Begum Ozbek, Hacer Neslihan Bildik, Cagman Tan, Sevil Oskay Halacli, Elif Soyak Aytekin, Saliha Esenboga, Sukru Cekic, Sara Sebnem Kilic, Ozlem Keskin, et al.

    Leukocyte adhesion deficiency type I is a rare primary immunodeficiency disorder characterized by mutations in the ITGB2 gene encoding CD18. We present clinical and immunological features of 15 patients with leukocyte adhesion deficiency type 1 (LAD-1). Targeted next-generation sequencing was performed with either a primary immunodeficiency gene panel comprising 266 genes or a small LAD-panel consisting of five genes for genetic analysis. To measure the expression level of integrins on the leukocyte surface, flow cytometry analysis was performed. The median age of the patients at diagnosis was 3 (1–48) months. Eleven (73%) of the 15 patients had a LAD-1 diagnosis in their first 6 months and 14 (93%) patients had consanguineous parents. Delayed separation of the umbilical cord was present in 80% (n = 12) of the patients in our cohort, whereas omphalitis was observed in 53% (n = 8) of the patients. Leukocytosis with neutrophil predominance was observed in 73% (n = 11) patients. Nine distinct variants in the ITGB2 gene in 13 of the 15 patients with LAD-1 were characterized, two of which (c.305_306delAA and c.779_786dup) are novel homozygous mutations of ITGB2. Four unrelated patients from Syria had a novel c.305_306delAA mutation that might be a founder effect for patients of Syrian origin. Four (27%) patients underwent hematopoietic stem cell transplantation. Two patients died because of HSCT complications and the other two are alive and well. Early differential diagnosis of the patients is critical in the management of the disease and genetic evaluation provides a basis for family studies and genetic counseling.


  • Male X-chromosome mosaicism leading to carrier phenotype and inheritance of chronic granulomatous disease

    by Stephanie Harris, Helen Braggins, Karin van Leeuwen, Kimberly Gilmour, Matthew S. Buckland, Dirk Roos, David M. Lowe


  • p47phox-/- Chronic Granulomatous Disease Patient with Incomplete Kawasaki Disease

    by Gouri P. Hule, Purva R. Kanvinde, Manasi A. Kulkarni, Karin van Leeuwen, Martin de Boer, Umair Ahmed Bargir, Prasad D. Taur, Mukesh M. Desai, Manisha R. Madkaikar


  • Two X-Linked Chronic Granulomatous Disease Patients with Unusual NADPH Oxidase Properties

    by Baruch Wolach, Arnon Broides, Tal Zeeli, Ronit Gavrieli, Martin de Boer, Karin van Leeuwen, Jacov Levy, Dirk Roos

    Chronic granulomatous disease (CGD) is an immune deficiency syndrome caused by defects in the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, the enzyme that generates reactive oxygen species (ROS) in phagocytizing leukocytes. This study evaluates the NADPH oxidase capacity in two X-linked CGD patients with mutations in gp91phox that alter the regions in this membrane-bound NADPH oxidase component involved in docking of the cytosolic component p47phox. Hydrogen peroxide and superoxide generation, bactericidal activity, and NADPH oxidase protein expression by the patients’ neutrophils were measured, and genetic analysis was performed. We report two patients, each with a novel missense mutation in CYBB, the gene that encodes gp91phox. Surprisingly, neutrophils from these patients showed total absence of superoxide production, although they retained 13–30% of the hydrogen peroxide production capability. We speculate that this is due to direct electron transfer from flavin adenine dinucleotide (FAD) in gp91phox to oxygen, leading to inefficient hydrogen peroxide formation instead of efficient superoxide production. X-linked CGD patients with mutations that alter the gp91phox protein in regions involved in docking of the cytosolic NADPH oxidase component p47phox may have higher than expected hydrogen peroxide generation capability.